Brokerages Anticipate Epizyme, Inc. (NASDAQ:EPZM) Will Announce Earnings of -$0.35 Per Share

Equities analysts expect Epizyme, Inc. (NASDAQ:EPZM – Get Rating) to announce earnings per share (EPS) of ($0.35) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Epizyme’s earnings, with the highest EPS estimate coming in at ($0.31) and the lowest estimate coming in at ($0.40). Epizyme posted earnings […]

Related Keywords

United States ,Thomson Reuter ,Pablog Legorreta ,Goldman Sachs Group Inc ,Zacks Investment Research ,Pinnacle Wealth Planning Services Inc ,Epizyme Inc ,Nasdaq ,Capital Partners ,Bioimpact Capital ,Epizyme Company Profile Get Rating ,Get Rating ,Zacks Investment ,Investment Research ,Director Pablo ,Sachs Group ,Impact Capital ,Pinnacle Wealth Planning Services ,Company Profile ,Epizyme ,Nasdaq Epzm ,Epzm ,Medical ,Ratings ,Consensus ,